SKI Market

Indian Indices

Nifty

25,966.05 170.90
(0.66%)

Sensex

84,778.84 566.96
( 0.67%)

Bank Nifty

58,114.25 414.65
( 0.72%)

Nifty IT

36,129.10 142.75
( 0.40%)

Global Indices

Nasdaq

47,566.16 338.04
(0.72%)

Dow Jones

6,896.21 83.52
(1.23%)

Hang Seng

50,457.07 1,157.42
(2.35%)

Nikkei 225

9,635.36 -10.26
(-0.11%)

Forex

USD-INR

87.83 0.08
(0.09%)

EUR-INR

101.91 0.09
(0.09%)

GBP-INR

117.11 -0.04
(-0.03%)

JPY-INR

0.58 0.00
(-0.39%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524558

INE794A01010

1182.3025819

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEULANDLAB

155.3

20260

EPS(TTM)

Face Value()

Div & Yield %

101.68

0.08

Back

Cipla Ltd - Product Launch - Lilly And Cipla Sign Marketing And Distribution Agreement For Second Brand Of Tirzepatide In India

Oct 23,2025

Lilly and Cipla sign marketing and distribution agreement for second brand of Tirzepatide in India

25,966.05 170.90 (0.66%)

84,778.84 566.96 ( 0.67%)

58,114.25 414.65 ( 0.72%)

36,129.10 142.75 ( 0.40%)

47,566.16 338.04 (0.72%)

6,896.21 83.52 (1.23%)

50,457.07 1,157.42 (2.35%)

9,635.36 -10.26 (-0.11%)

87.83 0.08 (0.09%)

101.91 0.09 (0.09%)

117.11 -0.04 (-0.03%)

0.58 0.00 (-0.39%)